Annulling a dangerous liaison: vaccination strategies against AIDS and tuberculosis
about
sameAs
Tuberculosis and HIV co-infectionCarbohydrate Recognition by RpfB from Mycobacterium tuberculosis Unveiled by Crystallographic and Molecular Dynamics AnalysesMolecular determinants of inactivation of the resuscitation promoting factor B from Mycobacterium tuberculosisProtein kinase E of Mycobacterium tuberculosis has a role in the nitric oxide stress response and apoptosis in a human macrophage model of infectionMycobacterium tuberculosis conserved hypothetical protein rRv2626c modulates macrophage effector functionsThe Mycobacterium tuberculosis LipB enzyme functions as a cysteine/lysine dyad acyltransferaseSerine protease activity contributes to control of Mycobacterium tuberculosis in hypoxic lung granulomas in miceInduction of IDO by bacille Calmette-Guérin is responsible for development of murine depressive-like behaviorMapping of Mycobacterium tuberculosis Complex Genetic Diversity Profiles in Tanzania and Other African CountriesGenome-wide association study of ancestry-specific TB risk in the South African Coloured populationAn interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosisMolecular analysis of a leprosy immunotherapeutic bacillus provides insights into Mycobacterium evolutionBoosting BCG with recombinant modified vaccinia ankara expressing antigen 85A: different boosting intervals and implications for efficacy trialsAnalysis of Mycobacterium tuberculosis-specific CD8 T-cells in patients with active tuberculosis and in individuals with latent infection.Infection with Helicobacter pylori is associated with protection against tuberculosis.Siderocalin inhibits the intracellular replication of Mycobacterium tuberculosis in macrophagesThe dynamics of immune responses to Mycobacterium tuberculosis during different stages of natural infection: A longitudinal study among Greenlanders.Immunoproteomic identification of human T cell antigens of Mycobacterium tuberculosis that differentiate healthy contacts from tuberculosis patients.The immunology of tuberculosis: from bench to bedside.Increased vaccine efficacy against tuberculosis of recombinant Mycobacterium bovis bacille Calmette-Guérin mutants that secrete listeriolysin.Clonotypic composition of the CD4+ T cell response to a vectored retroviral antigen is determined by its speed.Comparative miRNA expression profiles in individuals with latent and active tuberculosis.Increased levels of BAFF and APRIL related to human active pulmonary tuberculosis.Can successful vaccines teach us how to induce efficient protective immune responses?Preferential infection and depletion of Mycobacterium tuberculosis-specific CD4 T cells after HIV-1 infection.The hbhA gene of Mycobacterium tuberculosis is specifically upregulated in the lungs but not in the spleens of aerogenically infected mice.Experimental ocular tuberculosis in guinea pigs.Immunostimulatory activity of major membrane protein II from Mycobacterium tuberculosisIncreases in human papillomavirus detection during early HIV infection among women in Zimbabwe.The roles of microRNAs on tuberculosis infection: meaning or myth?A mycolic acid-specific CD1-restricted T cell population contributes to acute and memory immune responses in human tuberculosis infectionThe tuberculosis vaccine candidate Bacillus Calmette-Guérin ΔureC::hly coexpressing human interleukin-7 or -18 enhances antigen-specific T cell responses in miceIdentification of serum microRNA biomarkers for tuberculosis using RNA-seqImmunostimulatory activity of recombinant Mycobacterium bovis BCG that secretes major membrane protein II of Mycobacterium leprae.Mycobacterium bovis Bacille Calmette-Guérin as a Vaccine Vector for Global Infectious Disease ControlProtective immune responses to a recombinant adenovirus type 35 tuberculosis vaccine in two mouse strains: CD4 and CD8 T-cell epitope mapping and role of gamma interferonDeciphering the Structural Requirements of Nucleoside Bisubstrate Analogues for Inhibition of MbtA in Mycobacterium tuberculosis: A FB-QSAR Study and Combinatorial Library Generation for Identifying Potential Hits.Improve protective efficacy of a TB DNA-HSP65 vaccine by BCG priming.Advances in tuberculosis vaccine strategies.Characterization of novel multiantigenic vaccine candidates with pan-HLA coverage against Mycobacterium tuberculosis.
P2860
Q21131403-0635969B-2740-4B24-B1BF-F97B9363B448Q27678529-0D9DE637-1EA5-4990-8C4B-27C92C0EE88BQ27681848-70547345-E16D-42A7-A32E-EAFB48A1DFE5Q28486937-BEB45DCE-7F3B-4D89-A285-0712AAF4B2C9Q28486947-7B8868C0-8EE2-41FC-87AD-7224974A838FQ28487332-F7012D2B-4AFB-4769-871F-3277724A0394Q28505858-87ABBC02-1493-4F86-962E-0FBE9B7E5212Q28508390-D369EE50-AA58-4048-829C-7BB98C2826CDQ28603212-C1080881-F929-409C-95A6-033EE03E3FEEQ28943324-2FC6E40E-2EF4-4C93-9B39-E80F4AF7B211Q29618105-B8C4BDA2-19AC-4961-AB29-B7FCF9BB4528Q33301325-DB680FA4-4272-4DDC-8A76-64DB25E547D5Q33303660-48A1000C-F1B3-44E7-9760-F8EA5823710CQ33444815-694ED565-7F68-49DD-AA21-D33861322FB2Q33526339-EBB3B538-E6D1-4CC0-A14F-4B33AA9408EDQ33658322-EAD60A9B-5B27-4F5F-BC63-159FE3AF49BCQ33751671-CBB598CB-FB2F-4855-AEA6-F648D58FECD3Q33770118-71A8095B-0B74-4A4C-B7F4-BCCD106CA89EQ33777367-361AE05D-11F7-4DC3-9E6E-BCA516F67DB0Q33919973-70487369-4DBC-429A-83A1-596E62C74DF6Q33993393-27EDCD1F-EA0A-4F66-894E-8F60C3899660Q34049337-FBA8DCB2-2857-46E9-9712-839136DA1C3DQ34311903-D6266549-A906-4AA0-8C7F-CAB2BBA4F0C7Q34409182-B9017CB6-3523-4ABE-8AD9-A4798AD84AECQ34420861-78C6D981-6C8C-4BDC-A4CD-5609A4449CE1Q34601730-A03E3D1C-01D4-409B-883C-45A86B9F6598Q34707924-75CA9941-10A1-4EDF-A770-5413B21B4A9BQ34738803-5EDEC9A3-DBFE-4FD1-A8E7-3215057808F1Q34743282-2FB2C727-EE97-43B7-98EF-DB5BD5DD8F9AQ34985202-2CD2B962-8DF1-47BE-8FB1-DFA4F79237B1Q35015787-76FD74A2-BC4F-4952-9759-64B5CD84CF70Q35043659-AF2FD8D1-A736-4AB3-A61D-C6FA93CE4F52Q35106435-79A933E5-6056-4BB3-9C28-858C63CB1A7EQ35217560-C75B2595-1184-4E53-A663-9418524CEC96Q35909944-AFBED711-6D0D-4ADC-8EE6-5650907B5100Q35949758-171C6240-DDAA-4C0A-9814-54D5A55CAB84Q36088913-B01EB95E-44EF-49D7-BDBC-2C9FA99DFD3EQ36094423-267D54F5-AEC2-4A25-9720-7195B6AA03C4Q36482518-C9EF42F0-B9EC-46DE-BDAD-0B3FE4FFAA26Q36668540-7A3F0831-282A-4C1C-A4C3-13A43B71BB64
P2860
Annulling a dangerous liaison: vaccination strategies against AIDS and tuberculosis
description
2005 nî lūn-bûn
@nan
2005 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Annulling a dangerous liaison: vaccination strategies against AIDS and tuberculosis
@ast
Annulling a dangerous liaison: vaccination strategies against AIDS and tuberculosis
@en
Annulling a dangerous liaison: vaccination strategies against AIDS and tuberculosis
@nl
type
label
Annulling a dangerous liaison: vaccination strategies against AIDS and tuberculosis
@ast
Annulling a dangerous liaison: vaccination strategies against AIDS and tuberculosis
@en
Annulling a dangerous liaison: vaccination strategies against AIDS and tuberculosis
@nl
prefLabel
Annulling a dangerous liaison: vaccination strategies against AIDS and tuberculosis
@ast
Annulling a dangerous liaison: vaccination strategies against AIDS and tuberculosis
@en
Annulling a dangerous liaison: vaccination strategies against AIDS and tuberculosis
@nl
P2860
P3181
P356
P1433
P1476
Annulling a dangerous liaison: vaccination strategies against AIDS and tuberculosis
@en
P2093
Andrew J McMichael
P2860
P2888
P3181
P356
10.1038/NM1221
P407
P577
2005-04-01T00:00:00Z